1H-Pyrano[3,4-b]benzofuran-3-acetamide, 6-(dimethylamino)-3,4,4a,9a-tetrahydro-1-(hydroxymethyl)-N-[(4-phenoxyphenyl)methyl]-, (1S,3S,4aS,9aR)-;BRD0418;BRD0418, 10 mM in DMSO;2-((1S,3S,4aS,9aR)-6-(Dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl)-N-(4-phenoxybenzyl)acet amide
BRD0418 is used for the study of coronary artery disease (CAD); it modulates tribbles pseudokinase 1 (TRIB1) expression and shifts hepatic lipid metabolism from lipogenesis to clearance.